Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies

Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells

(2018) Giuseppina Barrera et al.   CURRENT MEDICINAL CHEMISTRY

Recent advances in malignant melanoma

(2017) Victoria Atkinson   INTERNAL MEDICINE JOURNAL

Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells

(2017) Laura Annovazzi et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)

(2017) Sonali Kumari et al.   Scientific Reports

Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, andin vitrocytotoxicity studies

(2016) Elena Peira et al.   JOURNAL OF MICROENCAPSULATION

Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation

(2016) Jeyarama S. Ananta et al.   NEUROLOGICAL RESEARCH

Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells

(2016) Guan Jiang et al.   ONCOLOGY REPORTS

Thrombin Cleavage of Osteopontin Modulates Its Activities in Human CellsIn Vitroand Mouse Experimental Autoimmune EncephalomyelitisIn Vivo

(2016) Elena Boggio et al.   Journal of Immunology Research

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

(2015) Chen Fang et al.   ACS Applied Materials & Interfaces

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

(2015) Sang-Soo Kim et al.   CANCER LETTERS

Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo

(2014) Guan Jiang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophages

(2014) Samuel Gehrke et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Solid Lipid Nanoparticles Loaded with Fluorescent-labelled Cyclosporine A: Anti-Inflammatory Activity In Vitro

(2014) Marina Gallarate et al.   PROTEIN AND PEPTIDE LETTERS

Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery

(2012) Luigi Battaglia et al.   Expert Opinion on Drug Delivery

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

(2011) Poulam M. Patel et al.   EUROPEAN JOURNAL OF CANCER

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53

(2011) Steven N. Reuland et al.   PLoS One

Solid lipid nanoparticles produced through a coacervation method

(2010) Luigi Battaglia et al.   JOURNAL OF MICROENCAPSULATION

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY